Sign in
4

Changes in Ownership

IGC Pharma, Inc. Filed Acc 0001185185-17-002244

Exec. Chairman & CEO returned 300,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

MUKUNDA RAM · Exec. Chairman & CEO

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2017-10-18 Returned to the company : show line 1 in the form −25,000 $0.41 $10,250 767,289 I
2017-10-18 Returned to the company : show line 2 in the form −25,000 $0.40 $10,000 742,289 I
2017-10-18 Returned to the company : show line 3 in the form −25,000 $0.40 $10,000 717,289 I
2017-10-18 Returned to the company : show line 4 in the form −25,000 $0.41 $10,250 692,289 I
2017-10-25 Returned to the company : show line 5 in the form −25,000 $0.41 $10,250 667,289 I
2017-10-25 Returned to the company : show line 6 in the form −11,834 $0.41 $4,852 655,455 I
2017-11-01 Returned to the company : show line 7 in the form −13,166 $0.45 $5,925 642,289 I
2017-11-01 Returned to the company : show line 8 in the form −25,000 $0.45 $11,250 617,289 I
2017-11-02 Returned to the company : show line 9 in the form −25,000 $0.46 $11,500 592,289 I
2017-11-03 Returned to the company : show line 10 in the form −100,000 $0.51 $51,000 492,289 I
Loading xslF345X03/form4-mukunda110217.xml…